Stock Events

Stock Events

Mineralys Therapeutics (MLYS) Q2 2026 Earnings

6MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.98

-0.81

-0.64

-0.47

Details

Expected EPS

-0.472157

Actual EPS

-0.47

Surprise EPS

0

Surprise Percent

+0.46%

Description

Mineralys Therapeutics (MLYS) has reported earnings of -0.47 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.